Splitting the dose isnt standard protocol and isnt supported by clinical data
Factors That Influence Your First-Month Weight Loss on Tirzepatide Your starting weight is one of the strongest predictors of first-month loss
Medical Writing and/or Editorial Assistance The authors thank Jin Heppell and Helen Marshall of Watermeadow Medical, an Ashfield Company, part of UDG Healthcare plc, for medical writing and editorial support (funded by Novo Nordisk Canada)
Coverage requirements depend on why your healthcare provider has prescribed Wegovy, but common criteria include a higher body mass index (BMI), a reduced-calorie diet, and increased physical activity
As GLP-1 and GIP receptors become less responsive to the compound, appetite suppression may fade, leading patients to consume more calories than before
Consult a healthcare provider before starting any peptide or protein therapy